Clinical Trials · NCT00446589

The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density

TerminatedPhase 4Teriparatide (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Papageorgiou General Hospital
Enrollment
19
Start date
Jul 2006
Locations
1 site, Greece
Primary endpoint
Effects of ibandronate and teriparatide on bone mineral density and bone histology in HD patients.
View Teriparatide compound reference